vs
MADRIGAL PHARMACEUTICALS, INC.（MDGL）与Thryv Holdings, Inc.（THRY）财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是Thryv Holdings, Inc.的1.9倍（$321.1M vs $167.7M），Thryv Holdings, Inc.净利率更高（2.7% vs -18.2%，领先21.0%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs -7.5%），Thryv Holdings, Inc.自由现金流更多（$-5.5M vs $-133.8M）
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
Thryv Holdings, Inc.是一家上市软件服务（SaaS）企业，面向中小企业提供客户关系管理与网络声誉管理软件解决方案。公司总部位于得克萨斯州达拉斯，业务覆盖美国48个州，现有员工超过2400名，其前身是多家黄页企业组成的集团。
MDGL vs THRY — 直观对比
营收规模更大
MDGL
是对方的1.9倍
$167.7M
营收增速更快
MDGL
高出218.3%
-7.5%
净利率更高
THRY
高出21.0%
-18.2%
自由现金流更多
THRY
多$128.4M
$-133.8M
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $321.1M | $167.7M |
| 净利润 | $-58.6M | $4.5M |
| 毛利率 | — | 65.2% |
| 营业利润率 | -18.6% | 37.3% |
| 净利率 | -18.2% | 2.7% |
| 营收同比 | 210.8% | -7.5% |
| 净利润同比 | 1.4% | 147.2% |
| 每股收益（稀释后） | $-2.55 | $0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDGLTHRY
| Q1 26 | — | $167.7M | ||
| Q4 25 | $321.1M | $191.6M | ||
| Q3 25 | $287.3M | $201.6M | ||
| Q2 25 | $212.8M | $210.5M | ||
| Q1 25 | $137.3M | $181.4M | ||
| Q4 24 | $103.3M | $186.6M | ||
| Q3 24 | $62.2M | $179.9M | ||
| Q2 24 | — | $224.1M |
净利润MDGLTHRY
| Q1 26 | — | $4.5M | ||
| Q4 25 | $-58.6M | $-9.7M | ||
| Q3 25 | $-114.2M | $5.7M | ||
| Q2 25 | $-42.3M | $13.9M | ||
| Q1 25 | $-73.2M | $-9.6M | ||
| Q4 24 | $-59.4M | $7.9M | ||
| Q3 24 | $-107.0M | $-96.1M | ||
| Q2 24 | — | $5.5M |
毛利率MDGLTHRY
| Q1 26 | — | 65.2% | ||
| Q4 25 | — | 68.0% | ||
| Q3 25 | — | 67.7% | ||
| Q2 25 | — | 69.7% | ||
| Q1 25 | 96.7% | 65.8% | ||
| Q4 24 | — | 65.9% | ||
| Q3 24 | — | 62.3% | ||
| Q2 24 | — | 66.3% |
营业利润率MDGLTHRY
| Q1 26 | — | 37.3% | ||
| Q4 25 | -18.6% | 5.3% | ||
| Q3 25 | -39.7% | 9.9% | ||
| Q2 25 | -22.2% | 14.0% | ||
| Q1 25 | -57.8% | -1.7% | ||
| Q4 24 | -64.8% | -3.9% | ||
| Q3 24 | -187.1% | -49.2% | ||
| Q2 24 | — | 14.0% |
净利率MDGLTHRY
| Q1 26 | — | 2.7% | ||
| Q4 25 | -18.2% | -5.0% | ||
| Q3 25 | -39.8% | 2.8% | ||
| Q2 25 | -19.9% | 6.6% | ||
| Q1 25 | -53.4% | -5.3% | ||
| Q4 24 | -57.5% | 4.2% | ||
| Q3 24 | -172.0% | -53.4% | ||
| Q2 24 | — | 2.5% |
每股收益（稀释后）MDGLTHRY
| Q1 26 | — | $0.10 | ||
| Q4 25 | $-2.55 | $-0.21 | ||
| Q3 25 | $-5.08 | $0.13 | ||
| Q2 25 | $-1.90 | $0.31 | ||
| Q1 25 | $-3.32 | $-0.22 | ||
| Q4 24 | $-2.50 | $0.28 | ||
| Q3 24 | $-4.92 | $-2.65 | ||
| Q2 24 | — | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.7M | $8.0M |
| 总债务越低越好 | $339.9M | — |
| 股东权益账面价值 | $602.7M | $225.4M |
| 总资产 | $1.3B | $693.7M |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势，按日历期对齐
现金及短期投资MDGLTHRY
| Q1 26 | — | $8.0M | ||
| Q4 25 | $198.7M | $10.8M | ||
| Q3 25 | $295.7M | $11.6M | ||
| Q2 25 | $186.2M | $10.8M | ||
| Q1 25 | $183.6M | $11.0M | ||
| Q4 24 | $100.0M | $16.3M | ||
| Q3 24 | $232.7M | $12.5M | ||
| Q2 24 | — | $15.5M |
总债务MDGLTHRY
| Q1 26 | — | — | ||
| Q4 25 | $339.9M | $253.5M | ||
| Q3 25 | $339.8M | $268.2M | ||
| Q2 25 | $118.4M | $275.6M | ||
| Q1 25 | $118.0M | $299.0M | ||
| Q4 24 | $117.6M | $284.3M | ||
| Q3 24 | $117.1M | $307.8M | ||
| Q2 24 | — | $342.1M |
股东权益MDGLTHRY
| Q1 26 | — | $225.4M | ||
| Q4 25 | $602.7M | $218.1M | ||
| Q3 25 | $625.7M | $221.1M | ||
| Q2 25 | $696.0M | $214.9M | ||
| Q1 25 | $710.6M | $193.2M | ||
| Q4 24 | $754.4M | $196.9M | ||
| Q3 24 | $777.2M | $94.5M | ||
| Q2 24 | — | $183.1M |
总资产MDGLTHRY
| Q1 26 | — | $693.7M | ||
| Q4 25 | $1.3B | $688.6M | ||
| Q3 25 | $1.4B | $701.8M | ||
| Q2 25 | $1.0B | $687.7M | ||
| Q1 25 | $996.6M | $703.7M | ||
| Q4 24 | $1.0B | $712.2M | ||
| Q3 24 | $1.1B | $654.8M | ||
| Q2 24 | — | $785.5M |
负债/权益比MDGLTHRY
| Q1 26 | — | — | ||
| Q4 25 | 0.56× | 1.16× | ||
| Q3 25 | 0.54× | 1.21× | ||
| Q2 25 | 0.17× | 1.28× | ||
| Q1 25 | 0.17× | 1.55× | ||
| Q4 24 | 0.16× | 1.44× | ||
| Q3 24 | 0.15× | 3.26× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-133.5M | — |
| 自由现金流经营现金流 - 资本支出 | $-133.8M | $-5.5M |
| 自由现金流率自由现金流/营收 | -41.7% | -3.3% |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $43.3M |
8季度趋势，按日历期对齐
经营现金流MDGLTHRY
| Q1 26 | — | — | ||
| Q4 25 | $-133.5M | $22.2M | ||
| Q3 25 | $79.8M | $22.2M | ||
| Q2 25 | $-47.1M | $29.6M | ||
| Q1 25 | $-88.9M | $-10.5M | ||
| Q4 24 | $-104.5M | $26.1M | ||
| Q3 24 | $-67.0M | $36.0M | ||
| Q2 24 | — | $22.2M |
自由现金流MDGLTHRY
| Q1 26 | — | $-5.5M | ||
| Q4 25 | $-133.8M | $12.3M | ||
| Q3 25 | $79.0M | $14.6M | ||
| Q2 25 | — | $21.8M | ||
| Q1 25 | — | $-17.6M | ||
| Q4 24 | $-104.7M | $17.3M | ||
| Q3 24 | $-67.8M | $27.5M | ||
| Q2 24 | — | $13.3M |
自由现金流率MDGLTHRY
| Q1 26 | — | -3.3% | ||
| Q4 25 | -41.7% | 6.4% | ||
| Q3 25 | 27.5% | 7.2% | ||
| Q2 25 | — | 10.4% | ||
| Q1 25 | — | -9.7% | ||
| Q4 24 | -101.3% | 9.3% | ||
| Q3 24 | -109.0% | 15.3% | ||
| Q2 24 | — | 5.9% |
资本支出强度MDGLTHRY
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 5.2% | ||
| Q3 25 | 0.3% | 3.8% | ||
| Q2 25 | 0.0% | 3.7% | ||
| Q1 25 | 0.0% | 3.9% | ||
| Q4 24 | 0.2% | 4.7% | ||
| Q3 24 | 1.3% | 4.7% | ||
| Q2 24 | — | 4.0% |
现金转化率MDGLTHRY
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 3.93× | ||
| Q2 25 | — | 2.12× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.32× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 4.01× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
THRY
| SaaS | $116.7M | 70% |
| Other | $50.9M | 30% |
